Related Experiment Video
Updated: Aug 29, 2025
Bone Marrow-derived Macrophage Production
Published on: November 22, 2013
The therapeutic potential of bone marrow-derived macrophages in neurological diseases
Kai Zhou1, Jinming Han2, Yafeng Wang1,3
1Henan Neurodevelopment Engineering Research Center for Children, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
Abstract:
Circulating monocytes are precursors of both tissue macrophages and dendritic cells, and they can infiltrate the central nervous system (CNS) where they transform into bone marrow-derived macrophages (BMDMs). BMDMs play essential roles in various CNS diseases, thus modulating BMDMs might be a way to treat these disorders because there are currently no efficient therapeutic methods available for most of these neurological diseases. Moreover, BMDMs can serve as promising gene delivery vehicles following bone marrow transplantation for otherwise incurable genetic CNS diseases. Understanding the distinct roles that BMDMs play in CNS diseases and their potential as gene delivery vehicles may provide new insights and opportunities for using BMDMs as therapeutic targets or delivery vehicles. This review attempts to comprehensively summarize the neurological diseases that might be treated by modulating BMDMs or by delivering gene therapies via BMDMs after bone marrow transplantation.
Insights
Bone marrow-derived macrophages (BMDMs) are crucial in central nervous system (CNS) diseases. Modulating BMDMs offers potential therapeutic strategies and gene delivery vehicles for neurological disorders.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Circulating monocytes differentiate into macrophages and dendritic cells.
- These cells can infiltrate the central nervous system (CNS), becoming bone marrow-derived macrophages (BMDMs).
- BMDMs are implicated in the pathology of various CNS diseases.
Purpose of the Study:
- To review the roles of BMDMs in neurological diseases.
- To explore the potential of BMDMs as therapeutic targets.
- To evaluate BMDMs as gene delivery vehicles for genetic CNS diseases.
Main Methods:
- Comprehensive literature review of studies on BMDMs in CNS diseases.
- Analysis of research on modulating BMDM function.
- Examination of studies utilizing BMDMs for gene therapy delivery.
Main Results:
- BMDMs play significant roles in the pathogenesis and progression of CNS disorders.
- Modulating BMDM activity presents a potential therapeutic avenue for neurological conditions.
- BMDMs show promise as cellular vehicles for gene therapy in genetic CNS diseases post-bone marrow transplantation.
Conclusions:
- Understanding BMDM functions in the CNS is critical for developing new treatments.
- Targeting BMDMs could offer novel therapeutic strategies for currently intractable neurological diseases.
- BMDMs represent a promising platform for gene therapy delivery in the central nervous system.
